Amarin | AMRN - Market Capitalization


Amarin reported $263.7M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 521.8B 77.2B Oct/2026
Alnylam Pharmaceuticals USD 22.44B 10.57B Oct/2026
Amarin USD 290M 51M Dec/2025
AstraZeneca USD 215.06B 74.93B Oct/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
DBV Technologies USD 1.23B 327M Mar/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 266.01B 25.42B Oct/2026